Abstract

RISK FACTORS FOR SURGICAL INTERVENTION OF EARLY MEDICAL ABORTION

Abire Abdalmahdi Hussein* and Israa Abdulmunem Mohammed

Abstract

Based on efficacy and adverse effect profile, evidence-based protocols for medical abortion are superior to the FDA-approved regimen. Vaginal, buccal, and sublingual routes of misoprostol administration increase efficacy, decrease continuing pregnancy rates and increase the gestational age range for use as compared with the FDA-approved regimen. Regimens that use low doses of mifepristone (200 mg) have similar efficacy and lower costs compared with to those that use mifepristone at 600 mg Women can safely and effectively selfadminister misoprostol at home as part of a medical abortion regimen. Medical abortion also can be provided safely and effectively by nonphysician clinicians. Follow-up after receiving mifepristone and misoprostol for medical abortion is important, although an in-clinic evaluation is not always necessary. Misoprostol-only medical abortion regimens are significantly less effective than those that use a combination of mifepristone and misoprostol.

Keywords: Surgical intervention, early medical abortion.